YouTubeVimeo
Alkomiet Hasan

Alkomiet Hasan

Member since 2016
born 1982
subject: Psychiatry, Psychotherapy, Clinical Neuroscience

Contact
Klinikum der Universität München
Klinik und Poliklinik für Psychiatrie and Psychotherapie
Nußbaumstr. 7
80336 München

Tel.: (089) 44 00-555 36
Fax: (089) 44 00-555 30
alkomiet.hasan@med.uni-muenchen.de

Personal web page

Research Areas

  • Schizophrenia and other psychotic disorders

  • Human Neurophysiology and Clinical Neurophysiology

  • Evidence-based medicine

  • Clinical Research and clinical trials

 

Curriculum Vitae

  • since 2015

    Vice Chairman, Department of Psychiatry and Psychotherapy, LMU Munich

  • 2014

    DGBP Research Prize for Systematic Neurosciences

  • 2014

    Consultant for Psychiatry, LMU Munich

  • 2014

    Board-certification for Psychiatry and Psychotherapy

  • 2013

    DGPPN Research Prize for Biological Psychiatry

  • 2013

    Aretaeus Schizophrenia Research Prize

  • 2013

    Habilitation (Venia docendi, Venia legend), Faculty of Medicine, LMU Munich

  • 2012

    Young Investigator Award International Congress on Schizophrenia Research

  • 2010

    DFG-Research Grant (University College London)

  • 2008

    Doctoral Thesis (Dr. med.), Faculty of Medicine, Georg-August University Göttingen

  • 2008

    Lincence to practice medicine

  • 2002 - 2008

    Studies of Medicine, Georg-August University Göttingen

Publications

  • Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial

    Hasan A, Guse B, Cordes J, Wölwer W, et al. (2016): Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial, Schizophr Bull. 42(3):608-18.

  • Left prefrontal high-frequency rTMS for the Treatment of Schizophrenia with Predominant Negative Symptoms - A Sham-controlled, Randomized Multicentre Trial

    Wobrock T, Guse B, Cordes J, Wölwer W, Winterer G, Gaebel W, Langguth B, Landgrebe M, Peter Eichhammer, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Malchow B, Schneider-Axmann T, Falkai P, Hasan A (2015): Left prefrontal high-frequency rTMS for the Treatment of Schizophrenia with Predominant Negative Symptoms - A Sham-controlled, Randomized Multicentre Trial, Biological Psychiatry, 1;77(11):979-88

  • Guidelines for Biological Treatment of Schizophrenia

    Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller HJ; the WFSBP Task Force on Treatment Guidelines for Schizophrenia (2012): World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 13(5):318-378

  • Nationale und internationale Leitlinien zur Schizophrenie

    Hasan A, Wobrock T, Gaebel W, Janssen B, Zielasek J, Falkai P (2013): Nationale und internationale Leitlinien zur Schizophrenie – Update 2013 zum Stand der Empfehlungen zur antipsychotischen Medikation, Der Nervenarzt, 84(11):1359-60

Recommend site